Previous studies have reported that ACSL4 could act as a tumor suppressor or oncogene, depending on the specific cancer type and tissue environment (Cheng et al., 2020; Ma et al., 2021; Lei et al., 2020; Zhang et al., 2021; Grube et al., 2022). Here, ACSL4 is linked to cancer.